Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.

Yoshii Y, Yoshimoto M, Matsumoto H, Furukawa T, Zhang MR, Inubushi M, Tsuji AB, Fujibayashi Y, Higashi T, Saga T.

Oncotarget. 2017 Sep 28;8(51):88815-88826. doi: 10.18632/oncotarget.21323. eCollection 2017 Oct 24.

2.

Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.

Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T.

Transl Oncol. 2018 Feb;11(1):24-30. doi: 10.1016/j.tranon.2017.10.006. Epub 2017 Nov 17.

3.

Hypoxia in cervical cancer: from biology to imaging.

Lyng H, Malinen E.

Clin Transl Imaging. 2017;5(4):373-388. doi: 10.1007/s40336-017-0238-7. Epub 2017 Jul 10. Review.

4.

Molecular mechanisms of hypoxia in cancer.

Challapalli A, Carroll L, Aboagye EO.

Clin Transl Imaging. 2017;5(3):225-253. doi: 10.1007/s40336-017-0231-1. Epub 2017 May 11. Review.

5.

Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.

Nie X, Randolph GJ, Elvington A, Bandara N, Zheleznyak A, Gropler RJ, Woodard PK, Lapi SE.

Nucl Med Biol. 2016 Sep;43(9):534-42. doi: 10.1016/j.nucmedbio.2016.05.011. Epub 2016 May 30.

6.

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Holland JP, Ferdani R, Anderson CJ, Lewis JS.

PET Clin. 2009 Jan;4(1):49-67. doi: 10.1016/j.cpet.2009.04.013.

7.

Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice.

Li F, Jørgensen JT, Madsen J, Kjaer A.

Diagnostics (Basel). 2015 Mar 27;5(2):96-112. doi: 10.3390/diagnostics5020096.

8.

First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Persson M, Skovgaard D, Brandt-Larsen M, Christensen C, Madsen J, Nielsen CH, Thurison T, Klausen TL, Holm S, Loft A, Berthelsen AK, Ploug M, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

Theranostics. 2015 Sep 13;5(12):1303-16. doi: 10.7150/thno.12956. eCollection 2015.

9.

Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.

Zornhagen KW, Hansen AE, Oxboel J, Clemmensen AE, El Ali HH, Kristensen AT, Kjær A.

PLoS One. 2015 Oct 26;10(10):e0141379. doi: 10.1371/journal.pone.0141379. eCollection 2015.

10.

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging.

Colombié M, Gouard S, Frindel M, Vidal A, Chérel M, Kraeber-Bodéré F, Rousseau C, Bourgeois M.

Front Med (Lausanne). 2015 Aug 24;2:58. doi: 10.3389/fmed.2015.00058. eCollection 2015. Review.

11.

64Cu-ATSM Hypoxia Positron Emission Tomography for Detection of Conduit Ischemia in an Experimental Rat Esophagectomy Model.

Park SY, Kang WJ, Cho A, Chae JR, Cho YL, Kim JY, Lee JW, Chung KY.

PLoS One. 2015 Jun 22;10(6):e0131083. doi: 10.1371/journal.pone.0131083. eCollection 2015.

12.

Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).

Lapi SE, Lewis JS, Dehdashti F.

Semin Nucl Med. 2015 Mar;45(2):177-85. doi: 10.1053/j.semnuclmed.2014.10.003. Review.

13.

Imaging tumour hypoxia with positron emission tomography.

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, Domarkas J, Lord S, Baldry C, Gilbert FJ.

Br J Cancer. 2015 Jan 20;112(2):238-50. doi: 10.1038/bjc.2014.610. Epub 2014 Dec 16. Review.

14.

Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Verwer EE, Boellaard R, van der Veldt AA.

World J Clin Oncol. 2014 Dec 10;5(5):824-44. doi: 10.5306/wjco.v5.i5.824. Review.

15.

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, Fonti C, Lodi F, Mattioli S, Fanti S.

Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014. Review.

16.

Current molecular imaging positron emitting radiotracers in oncology.

Zhu A, Shim H.

Nucl Med Mol Imaging. 2011 Mar;45(1):1-14. doi: 10.1007/s13139-011-0075-y. Epub 2011 Feb 1. Review.

17.

Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.

Black KC, Wang Y, Luehmann HP, Cai X, Xing W, Pang B, Zhao Y, Cutler CS, Wang LV, Liu Y, Xia Y.

ACS Nano. 2014 May 27;8(5):4385-94. doi: 10.1021/nn406258m. Epub 2014 Apr 30.

18.

Molecular imaging of tumor hypoxia with positron emission tomography.

Kelada OJ, Carlson DJ.

Radiat Res. 2014 Apr;181(4):335-49. doi: 10.1667/RR13590.1. Epub 2014 Mar 27. Review.

19.

A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.

Carlin S, Zhang H, Reese M, Ramos NN, Chen Q, Ricketts SA.

J Nucl Med. 2014 Mar;55(3):515-21. doi: 10.2967/jnumed.113.126615. Epub 2014 Feb 3.

20.

Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.

Yoshii Y, Matsumoto H, Yoshimoto M, Furukawa T, Morokoshi Y, Sogawa C, Zhang MR, Wakizaka H, Yoshii H, Fujibayashi Y, Saga T.

PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014.

Supplemental Content

Support Center